+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Immunomodulators Market - Global Forecast 2026-2032- Product Image
Veterinary Immunomodulators Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Immunomodulators Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129190
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Immunomodulators Market is projected to reach USD 1.47 Billion in 2026. It is expected to continue growing at a CAGR of 8.36%, reaching USD 2.38 Billion by 2032.

Veterinary Immunomodulators: Executive Overview

Veterinary immunomodulators are used to influence immune responses in animals, including immune stimulation, immune regulation, and management of inflammatory or infectious conditions. Their relevance spans companion animals, livestock, aquaculture, and other managed animal populations. Demand is shaped by animal-health priorities, veterinary practice standards, disease-prevention programs, production efficiency goals, and the need to reduce avoidable antimicrobial use while maintaining animal welfare.

Prevention, Stewardship, and Precision Care Are Reshaping Use

The landscape is shifting from reactive treatment toward prevention, early intervention, and more targeted immune management. Growing attention to antimicrobial stewardship, zoonotic disease preparedness, vaccination support, biosecurity, and welfare is increasing interest in therapies that can complement-not replace-diagnostics, vaccines, hygiene, and sound husbandry. Adoption also depends on evidence quality, regulatory clarity, administration practicality, species-specific safety, and the ability of veterinarians and producers to monitor outcomes consistently.

Artificial Intelligence Strengthens Evidence, Diagnosis, and Deployment

Artificial intelligence can support veterinary immunomodulator development and use by identifying response patterns in clinical, genomic, imaging, and production data. Applications include trial design, patient stratification, adverse-event detection, disease surveillance, diagnostic decision support, and optimization of treatment timing. However, implementation requires validated datasets across species and regions, explainable models, robust privacy and cybersecurity controls, and veterinary oversight. AI should augment clinical judgment rather than independently determine therapy selection.

Regional Insights: Regulation, Production Systems, and Disease Priorities Differ

North America emphasizes evidence-based veterinary practice, companion-animal care, livestock biosecurity, and antimicrobial stewardship. Latin America is strongly influenced by livestock production, export requirements, disease-control programs, and uneven access to veterinary services. Europe places substantial weight on animal welfare, environmental considerations, traceability, and prudent medicine use. The Middle East faces varied disease pressures across intensive and pastoral systems, while Africa’s priorities include affordability, access, endemic disease control, and infrastructure. Asia-Pacific combines large livestock and aquaculture populations with rapidly modernizing companion-animal markets, creating diverse needs for scalable and species-appropriate immune-management solutions.

Group Insights: Trade, Regulation, and Security Shape Adoption

ASEAN markets reflect varied regulatory systems, tropical disease burdens, aquaculture activity, and expanding demand for affordable animal-health solutions. BRICS members combine major livestock populations with diverse production models and differing regulatory capacity, making local evidence and distribution access important. The European Union is shaped by harmonized rules, welfare expectations, traceability, and antimicrobial stewardship. G7 markets generally have mature veterinary infrastructure, demanding evidence standards, and strong surveillance capabilities. GCC countries emphasize food-security resilience, imported animal-health expertise, and intensive production systems. NATO members may benefit from coordinated preparedness perspectives, although veterinary-health regulation remains primarily national or regional.

Country Insights: National Priorities Require Localized Strategies

Australia emphasizes biosecurity, livestock health, and geographically dispersed veterinary access. Brazil combines large-scale livestock production with export-sensitive disease management. Canada balances companion-animal care, livestock systems, and extensive geography. China has broad demand across livestock, aquaculture, and companion animals, alongside evolving regulatory requirements. France, Germany, Italy, and Spain operate within European welfare, traceability, and prudent-use frameworks while retaining distinct production and clinical profiles. India’s priorities include affordability, animal productivity, disease prevention, and uneven service availability. Japan and South Korea have advanced veterinary systems and strong companion-animal engagement. Mexico reflects livestock, companion-animal, and regional disease-control needs. Russia’s market context is influenced by domestic production, supply resilience, and regulatory conditions. The United Kingdom places emphasis on animal welfare, surveillance, and responsible medicine use. The United States combines specialized clinical care, advanced diagnostics, livestock biosecurity, and rigorous product oversight.

Recommendations for Leaders: Build Evidence, Access, and Responsible Adoption

Industry leaders should prioritize species-specific clinical evidence, clearly defined immune-response endpoints, and comparative studies that demonstrate practical value alongside standard care. Regulatory and medical-affairs teams should engage authorities early, document safety and responsible-use conditions, and align claims with validated outcomes. Commercial strategies should be tailored to regional disease priorities, veterinary capacity, production systems, and affordability constraints rather than relying on a single global model. Partnerships with diagnostic providers, veterinary institutions, producer organizations, and surveillance networks can improve implementation. Leaders should also establish pharmacovigilance, resistance-monitoring where relevant, training programs, and AI governance processes before scaling digitally enabled decision support.

Research Methodology: Structured Review of Veterinary Immunomodulator Evidence

This executive summary is based on a structured assessment of veterinary immunomodulators across therapeutic roles, species applications, regulatory considerations, clinical practice, production systems, and regional operating conditions. The analysis organizes insights by geography and economic or institutional grouping, including North America, Latin America, Europe, the Middle East, Africa, Asia-Pacific, ASEAN, BRICS, the European Union, the G7, the GCC, and NATO. Country-level interpretation considers veterinary infrastructure, animal-production patterns, disease-control priorities, stewardship expectations, and policy context. Findings are framed qualitatively and avoid market estimates, market sizing, forecasts, market shares, and company-specific claims.

Conclusion: Responsible Immune Management Supports Resilient Animal Health

Veterinary immunomodulators have a meaningful role within broader animal-health strategies that combine prevention, diagnostics, vaccination, biosecurity, nutrition, welfare, and responsible therapeutic use. The strongest opportunities are likely to emerge where products are supported by credible evidence, clear regulation, practical administration, and measurable outcomes for animals, veterinarians, and producers. Regional and country differences make localization essential, while AI can improve targeting and surveillance when governed carefully. Sustainable progress will depend on integrating innovation with antimicrobial stewardship, affordability, access, and One Health principles.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Immunomodulators Market, by Product Type
7.1. Introduction
7.2. Cytokines
7.2.1. Colony Stimulating Factors
7.2.2. Interferons
7.2.3. Interleukins
7.2.4. Tumor Necrosis Factors
7.3. Immunostimulants
7.3.1. Bacterial Derivatives
7.3.2. Plant Extracts
7.4. Monoclonal Antibodies
7.4.1. Chimeric
7.4.2. Fully Human
7.4.3. Humanized
7.4.4. Murine
7.5. Toll Like Receptor Agonists
7.6. Vaccines
7.6.1. Conjugate
7.6.2. Inactivated
7.6.3. Live Attenuated
7.6.4. Recombinant
7.6.5. Subunit
8. Veterinary Immunomodulators Market, by Animal Type
8.1. Introduction
8.2. Aquaculture
8.2.1. Crustaceans
8.2.2. Fish
8.2.3. Mollusks
8.3. Companion Animals
8.3.1. Cats
8.3.2. Dogs
8.4. Livestock
8.4.1. Cattle
8.4.2. Poultry
8.4.3. Swine
9. Veterinary Immunomodulators Market, by Route Of Administration
9.1. Introduction
9.2. Intramuscular
9.3. Intravenous
9.4. Oral
9.5. Subcutaneous
10. Veterinary Immunomodulators Market, by Disease Indication
10.1. Introduction
10.2. Allergies
10.3. Autoimmune Disorders
10.4. Cancer
10.5. Infectious Diseases
11. Veterinary Immunomodulators Market, by Application
11.1. Introduction
11.2. Prophylactic
11.2.1. Active Immunization
11.2.2. Passive Immunization
11.3. Therapeutic
11.3.1. Allergy Management
11.3.2. Autoimmune Disorders Treatment
11.3.3. Cancer Therapy
11.3.4. Infectious Diseases Treatment
11.3.5. Wound Healing
12. Veterinary Immunomodulators Market, by End User
12.1. Introduction
12.2. Animal Research Laboratories
12.3. Pharmaceutical Companies
12.4. Veterinary Hospitals Clinics
13. Veterinary Immunomodulators Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Veterinary Immunomodulators Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Veterinary Immunomodulators Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Boehringer Ingelheim International GmbH
17.2. Ceva Santé Animale
17.3. Dechra Pharmaceuticals PLC
17.4. Elanco Animal Health Incorporated
17.5. Heska Corporation
17.6. HIPRA, S.A.
17.7. IDEXX Laboratories, Inc.
17.8. Jurox Pty Ltd.
17.9. Kela N.V.
17.10. Merck & Co., Inc.
17.11. MSD Animal Health
17.12. Neogen Corporation
17.13. PetIQ, Inc.
17.14. Phibro Animal Health Corporation
17.15. Safe-Guard Products LLC
17.16. Vaxxinova Group
17.17. Vetoquinol S.A.
17.18. Virbac S.A.
17.19. Zoetis Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Veterinary Immunomodulators Market, Years Considered for the Study
FIGURE 2. Global Veterinary Immunomodulators Market, Research Design
FIGURE 3. Global Veterinary Immunomodulators Market, Research Framework
FIGURE 4. Global Veterinary Immunomodulators Market, Data Triangulation
FIGURE 5. Global Veterinary Immunomodulators Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Veterinary Immunomodulators Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Veterinary Immunomodulators Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Veterinary Immunomodulators Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 9. Global Veterinary Immunomodulators Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Veterinary Immunomodulators Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Veterinary Immunomodulators Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Veterinary Immunomodulators Market Size, by Disease Indication, 2025 vs 2032 (%)
FIGURE 13. Global Veterinary Immunomodulators Market Size, by Disease Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Veterinary Immunomodulators Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Veterinary Immunomodulators Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Veterinary Immunomodulators Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Veterinary Immunomodulators Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Veterinary Immunomodulators Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Veterinary Immunomodulators Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Veterinary Immunomodulators Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Veterinary Immunomodulators Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Veterinary Immunomodulators Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Veterinary Immunomodulators Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Veterinary Immunomodulators Market Segmentation & Coverage
TABLE 2. Global Veterinary Immunomodulators Market Size, 2017-2032 (USD Million)
TABLE 3. Global Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Cytokines Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cytokines Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cytokines Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Colony Stimulating Factors Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Colony Stimulating Factors Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Colony Stimulating Factors Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Interferons Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Interferons Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Interferons Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Interleukins Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Interleukins Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Interleukins Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Tumor Necrosis Factors Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Tumor Necrosis Factors Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Tumor Necrosis Factors Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Immunostimulants Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Immunostimulants Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Immunostimulants Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Bacterial Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Bacterial Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Bacterial Derivatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Plant Extracts Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Plant Extracts Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Plant Extracts Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Chimeric Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Chimeric Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Chimeric Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Fully Human Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Fully Human Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Fully Human Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Humanized Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Humanized Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Humanized Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Murine Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Murine Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Murine Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Toll Like Receptor Agonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Toll Like Receptor Agonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Toll Like Receptor Agonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Conjugate Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Conjugate Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Conjugate Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Inactivated Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Inactivated Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Inactivated Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Live Attenuated Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Live Attenuated Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Live Attenuated Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Recombinant Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Recombinant Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Recombinant Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Subunit Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Subunit Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Subunit Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 65. Global Aquaculture Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Aquaculture Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Aquaculture Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Crustaceans Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Crustaceans Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Crustaceans Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Fish Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Fish Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Fish Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Mollusks Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Mollusks Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Mollusks Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Swine Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Swine Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Swine Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 99. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 112. Global Allergies Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Allergies Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Allergies Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Autoimmune Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Autoimmune Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Autoimmune Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Global Prophylactic Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Prophylactic Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Prophylactic Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Active Immunization Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Active Immunization Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Active Immunization Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Passive Immunization Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Passive Immunization Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Passive Immunization Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Allergy Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Allergy Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Allergy Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Autoimmune Disorders Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Autoimmune Disorders Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Autoimmune Disorders Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Cancer Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Cancer Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Cancer Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Infectious Diseases Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Infectious Diseases Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Infectious Diseases Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Wound Healing Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Wound Healing Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Wound Healing Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Global Animal Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Animal Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Animal Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Veterinary Hospitals Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Veterinary Hospitals Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Veterinary Hospitals Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Veterinary Immunomodulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Veterinary Immunomodulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. North America Veterinary Immunomodulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. North America Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. North America Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 182. North America Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 183. North America Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 184. North America Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 185. North America Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 186. North America Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 187. North America Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 188. North America Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 189. North America Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 190. North America Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 191. North America Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. North America Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 193. North America Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 194. North America Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Latin America Veterinary Immunomodulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Latin America Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. Latin America Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 198. Latin America Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 199. Latin America Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 200. Latin America Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 201. Latin America Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 202. Latin America Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 203. Latin America Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 204. Latin America Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 205. Latin America Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 206. Latin America Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 207. Latin America Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Latin America Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 209. Latin America Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 210. Latin America Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Europe Veterinary Immunomodulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Europe Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 213. Europe Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 214. Europe Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 215. Europe Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 216. Europe Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 217. Europe Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 218. Europe Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 219. Europe Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 220. Europe Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 221. Europe Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 222. Europe Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 223. Europe Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Europe Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 225. Europe Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 226. Europe Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Middle East Veterinary Immunomodulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Middle East Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. Middle East Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 230. Middle East Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 231. Middle East Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 232. Middle East Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 233. Middle East Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 234. Middle East Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 235. Middle East Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 236. Middle East Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 237. Middle East Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 238. Middle East Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 239. Middle East Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Middle East Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 241. Middle East Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 242. Middle East Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Africa Veterinary Immunomodulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 244. Africa Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. Africa Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 246. Africa Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 247. Africa Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 248. Africa Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 249. Africa Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 250. Africa Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 251. Africa Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 252. Africa Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 253. Africa Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 254. Africa Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 255. Africa Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. Africa Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 257. Africa Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 258. Africa Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Global Veterinary Immunomodulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 260. ASEAN Veterinary Immunomodulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. ASEAN Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. ASEAN Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 263. ASEAN Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 264. ASEAN Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 265. ASEAN Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 266. ASEAN Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 267. ASEAN Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 268. ASEAN Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 269. ASEAN Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 270. ASEAN Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 271. ASEAN Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 272. ASEAN Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. ASEAN Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 274. ASEAN Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 275. ASEAN Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. GCC Veterinary Immunomodulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. GCC Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. GCC Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 279. GCC Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 280. GCC Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 281. GCC Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 282. GCC Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 283. GCC Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 284. GCC Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 285. GCC Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 286. GCC Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 287. GCC Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 288. GCC Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. GCC Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 290. GCC Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 291. GCC Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. European Union Veterinary Immunomodulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 293. European Union Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 294. European Union Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 295. European Union Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 296. European Union Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 297. European Union Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 298. European Union Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 299. European Union Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 300. European Union Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 301. European Union Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 302. European Union Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 303. European Union Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 304. European Union Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. European Union Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 306. European Union Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 307. European Union Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. BRICS Veterinary Immunomodulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 309. BRICS Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. BRICS Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 311. BRICS Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 312. BRICS Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 313. BRICS Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 314. BRICS Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 315. BRICS Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 316. BRICS Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 317. BRICS Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 318. BRICS Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 319. BRICS Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 320. BRICS Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. BRICS Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 322. BRICS Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 323. BRICS Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. G7 Veterinary Immunomodulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 325. G7 Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 326. G7 Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 327. G7 Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 328. G7 Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 329. G7 Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 330. G7 Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 331. G7 Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 332. G7 Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 333. G7 Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 334. G7 Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 335. G7 Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 336. G7 Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 337. G7 Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 338. G7 Veterinary Immunomodulators Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 339. G7 Veterinary Immunomodulators Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. NATO Veterinary Immunomodulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 341. NATO Veterinary Immunomodulators Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 342. NATO Veterinary Immunomodulators Market Size, by Cytokines, 2017-2032 (USD Million)
TABLE 343. NATO Veterinary Immunomodulators Market Size, by Immunostimulants, 2017-2032 (USD Million)
TABLE 344. NATO Veterinary Immunomodulators Market Size, by Monoclonal Antibodies, 2017-2032 (USD Million)
TABLE 345. NATO Veterinary Immunomodulators Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 346. NATO Veterinary Immunomodulators Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 347. NATO Veterinary Immunomodulators Market Size, by Aquaculture, 2017-2032 (USD Million)
TABLE 348. NATO Veterinary Immunomodulators Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 349. NATO Veterinary Immunomodulators Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 350. NATO Veterinary Immunomodulators Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 351. NATO Veterinary Immunomodulators Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 352. NATO Veterinary Immunomodulators Market Size, by Application, 2017-2032 (USD Million)
TABLE 353. NATO Veterinary Immunomodulators Market Size, by Prophylactic, 2017-2032 (USD Million)
TABLE 354. NATO Veterinary Immunomodulators Market Size, by Therapeutic, 2017

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • HIPRA, S.A.
  • IDEXX Laboratories, Inc.
  • Jurox Pty Ltd.
  • Kela N.V.
  • Merck & Co., Inc.
  • MSD Animal Health
  • Neogen Corporation
  • PetIQ, Inc.
  • Phibro Animal Health Corporation
  • Safe‑Guard Products LLC
  • Vaxxinova Group
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Immunomodulator Market Report 2026 - Product Image

Immunomodulator Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Immunomodulators Market Report by Product, Application, and Region 2026-2034 - Product Image

Immunomodulators Market Report by Product, Application, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Immunomodulators Market - Global Forecast 2026-2032 - Product Image

Immunomodulators Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Immunomodulators - Global Strategic Business Report - Product Image

Immunomodulators - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Immunomodulators - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Immunomodulators - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 119 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.